Skip to main content

Table 1 Patient demographics and characteristics

From: Characterization of immunologically detectable T-cell sensitization, Immunohistochemical detection of pro-inflammatory cytokines, and clinical parameters of patients after allogeneic intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans

 

Maxgraft® (N = 25)

Puros® (N = 25)

Control (N = 10)

sex, n

 male

15

12

7

 female

10

13

3

age, years

 mean ± SD

58.1 ± 11.4

56.3 ± 13.4

55.2 ± 9.5

 min; max

38.8; 78.3

28.8; 73.6

31.8; 76.3

treated region, n

 maxilla

17

18

5

 mandible

8

7

5

treated tooth/teeth, n

 anterior

6

8

2

 posterior

19

17

8

healing period, months

 mean ± SD

4.3 ± 1.1

4.2 ± 0.9

4,1 ± 0.7

 min; max

4.0; 5.0

4.0; 4.8

4.0; 4.7

  1. SD Standard deviation, min Minimum, max Maximum
  2. Table 1 shows the patient demographics and characteristics regarding sex, age, treated region in the mouth and healing period in months
Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us